Myomo Inc (MYO) Stock Price, Quote & News

Company Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interfac...

Industry: Medical Devices

Sector: Healthcare

Phone: 617 996 9058

Website: myomo.com

Address:

45 Blue Sky Dr., Suite 101, Burlington, United States

StockOperator69 Jul. 6 at 11:03 PM

$MYO insider buys just going to watch and see where the bottoms at someone definitely loaded up so could see a run in the future but not sure if we’ve hit the bottom

1 · Reply

xbizo Jul. 5 at 3:22 PM

$MYO Let's give it a rest and focus on what is changing now. There are good thinkers on this board, and everyone comes with biases. Plus circumstance and viewpoint change over time. The one thing that has changed since investor day is the price. Is $2 a good entry price?

0 · Reply

DeanJ7575 Jul. 4 at 11:52 AM

$MYO Official Launch of MyoPro at Artalive Malaysia Artalive Malaysia is proud to announce the official launch of MyoPro®️, a powerful orthotic specially designed to help individuals who suffer from paralysis or weakness in the arms and hands due to neurological conditions. Developed in the United States and clinically proven, MyoPro is now offered exclusively by ArtaLive – making Malaysia the first country in Southeast Asia to introduce this technology to the public.

2 · Reply

alexpitti Jul. 4 at 12:15 AM

$MYO loved it at $5 hates it at $2.2 lmao

1 · Reply

alexpitti Jul. 3 at 10:11 PM

been a tough 6 weeks for $DCTH and $MYO still holding strong. others have been flattish. have a happy 4th of july $STXS $VFC $ABEO

1 · Reply

Big_Baggies Jul. 3 at 7:30 PM

$MYO Management's 2024 press release about them becoming in-network with BCBS/Massachusetts was disingenuous/misleading. They are covering L8701 L8702 only for missing limbs...in other words, they arent covering the myopro. Being in-network is irrelevant. They got me there with that PR.

2 · Reply

xbizo Jul. 3 at 6:37 PM

$MYO Started building a new position today at $2.05. Had exited after the $100MM 2028 investor day. May not be the best idea I've ever had - that is to buy a falling knife before the bottom is clearly in....

1 · Reply

kurtb1969 Jul. 3 at 4:48 PM

$MYO is trading at 2.1x sales, $EKSO is trading at 0.29x sales and $LFWD 0.33x sales after recent dilution. These stocks have traded at 10-100x sales in the past.

0 · Reply

DeanJ7575 Jul. 3 at 4:45 PM

$MYO bottom line is we need new management - if I’m wrong, please post

2 · Reply

kurtb1969 Jul. 3 at 4:43 PM

$MYO is 1 year ahead of $LFWD and 2 years ahead of $EKSO. Ekso has had to build a business from scratch selling to individuals. As myo can attest that takes a while. The best time to buy tiny companies is when there is maximum pessimism. myo can easily go up 5x and ekso, lfwd 10-20x within 5 years.

0 · Reply

Myomo Provides Highlights of Today's Investor & Analyst Day Event

May 7, 2025, 9:00 PM EDT - 2 months ago

Myomo, Inc. (MYO) Q1 2025 Earnings Call Transcript

May 7, 2025, 5:11 PM EDT - 2 months ago

Myomo Reports First Quarter 2025 Financial and Operating Results

May 1, 2025, 8:30 AM EDT - 2 months ago

Myomo to Host Investor & Analyst Day Event on June 18, 2025

Apr 30, 2025, 4:05 PM EDT - 2 months ago

Myomo to Report First Quarter 2025 Financial Results on May 7

Apr 30, 2025, 8:05 AM EDT - 2 months ago

Myomo Launches the MyoPro® 2x

Apr 10, 2025, 8:30 AM EDT - 3 months ago

Myomo Announces Upcoming Changes to its Board of Directors

Mar 31, 2025, 4:05 PM EDT - 3 months ago

Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 10, 2025, 6:13 PM EDT - 4 months ago

Myomo, Inc. (MYO) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 4:05 PM EDT - 4 months ago

Myomo's Fourth Quarter Financial Results Feature Record Revenue of $12.1 Million

Mar 3, 2025, 4:05 PM EST - 4 months ago

Myomo to Report Fourth Quarter 2024 Financial Results on March 10

Dec 5, 2024, 7:30 AM EST - 7 months ago

Myomo, Inc. Prices $15.0 Million Public Offering of Common Stock

Dec 4, 2024, 4:05 PM EST - 7 months ago

Myomo, Inc. Announces Proposed Public Offering of Common Stock

Nov 6, 2024, 10:11 PM EST - 8 months ago

Myomo, Inc. (MYO) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:05 PM EST - 8 months ago

Myomo Reports Record Third Quarter Financial and Operating Results

Nov 5, 2024, 3:30 PM EST - 8 months ago

CMS Decision And O&P Network Build Out Make Myomo A Buy

Oct 31, 2024, 4:05 PM EDT - 8 months ago

Myomo Announces First Private Payer Contracts for MyoPro In-network Coverage

Oct 30, 2024, 4:05 PM EDT - 8 months ago

Myomo to Report Third Quarter Financial Results on November 6, 2024

Oct 9, 2024, 4:05 PM EDT - 9 months ago

Myomo to Participate in the 2024 Maxim Healthcare Virtual Summit

Sep 12, 2024, 8:30 AM EDT - 10 months ago

Myomo, Inc. Announces the Launch of Myomo Academy at AOPA National Assembly

Sep 5, 2024, 4:15 PM EDT - 10 months ago

Myomo to Participate in Two Investor Conferences in September

Aug 9, 2024, 11:03 AM EDT - 11 months ago

Myomo, Inc. (MYO) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 11 months ago

Myomo Reports Second Quarter 2024 Financial Results

Jul 30, 2024, 4:05 PM EDT - 1 year ago

Myomo to Report Second Quarter Financial Results on August 6, 2024

Jul 8, 2024, 8:30 AM EDT - 1 year ago

Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics

Jun 5, 2024, 5:58 PM EDT - 1 year ago

Myomo to Present at the Sidoti Virtual Investor Conference on June 12-13, 2024

May 8, 2024, 10:03 PM EDT - 1 year ago

Myomo, Inc. (MYO) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 1 year ago

Myomo Reports First Quarter 2024 Financial Results

May 6, 2024, 8:30 AM EDT - 1 year ago

Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

May 1, 2024, 5:21 PM EDT - 1 year ago

Myomo to Report First Quarter Financial Results on May 8, 2024

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Myomo Appoints Heather Getz to its Board of Directors

Mar 13, 2024, 6:55 AM EDT - 1 year ago

Myomo's Revolutionary MyoPro Brace: A Buy In Neurological Mobility Aid

Mar 10, 2024, 3:00 AM EDT - 1 year ago

Myomo, Inc.: In Motion To Accelerating Revenue Growth

Mar 7, 2024, 8:10 PM EST - 1 year ago

Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:05 PM EST - 1 year ago

Myomo Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 1, 2024, 8:00 AM EST - 1 year ago

CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro®

Feb 29, 2024, 4:05 PM EST - 1 year ago

Myomo to Report Fourth Quarter Financial Results on March 7, 2024

Jan 19, 2024, 4:05 PM EST - 1 year ago

Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Jan 17, 2024, 8:05 AM EST - 1 year ago

Myomo Announces $6 Million Registered Direct Offering of Common Stock Priced At-the-Market

Jan 17, 2024, 8:00 AM EST - 1 year ago

Myomo Reports Preliminary Fourth Quarter Revenue and Backlog

Dec 1, 2023, 1:32 PM EST - 1 year ago

Myomo: Market Severely Undervaluing Opportunity

Nov 7, 2023, 6:28 PM EST - 1 year ago

Myomo, Inc. (MYO) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 1 year ago

Myomo Reports Third Quarter 2023 Financial Results Featuring Record Product Revenue and Authorizations

Nov 6, 2023, 8:30 AM EST - 1 year ago

CMS Posts Proposed Medicare DMEPOS Fee Schedule Rate for the MyoPro® for Review at the Upcoming HCPCS Public Meeting

Nov 2, 2023, 10:08 AM EDT - 1 year ago

Myomo Announces that CMS has Classified the MyoPro Orthosis Under the Brace Benefit Category

Oct 31, 2023, 4:05 PM EDT - 1 year ago

Myomo to Report Third Quarter Financial Results on November 7, 2023

Sep 5, 2023, 9:00 AM EDT - 1 year ago

Myomo: Game-Changing Medicare Reimbursement Should Create Lasting Value

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Myomo Announces Closing of $4.4 Million Public Offering

Aug 25, 2023, 7:00 AM EDT - 2 years ago

Myomo Announces Pricing of $4.4 Million Public Offering

Aug 24, 2023, 4:15 PM EDT - 2 years ago

Myomo, Inc. Announces Proposed Public Offering

StockOperator69 Jul. 6 at 11:03 PM

$MYO insider buys just going to watch and see where the bottoms at someone definitely loaded up so could see a run in the future but not sure if we’ve hit the bottom

1 · Reply

xbizo Jul. 5 at 3:22 PM

0 · Reply

DeanJ7575 Jul. 4 at 11:52 AM

2 · Reply

alexpitti Jul. 4 at 12:15 AM

$MYO loved it at $5 hates it at $2.2 lmao

1 · Reply

alexpitti Jul. 3 at 10:11 PM

been a tough 6 weeks for $DCTH and $MYO still holding strong. others have been flattish. have a happy 4th of july $STXS $VFC $ABEO

1 · Reply

Big_Baggies Jul. 3 at 7:30 PM

2 · Reply

xbizo Jul. 3 at 6:37 PM

1 · Reply

kurtb1969 Jul. 3 at 4:48 PM

$MYO is trading at 2.1x sales, $EKSO is trading at 0.29x sales and $LFWD 0.33x sales after recent dilution. These stocks have traded at 10-100x sales in the past.

0 · Reply

DeanJ7575 Jul. 3 at 4:45 PM

$MYO bottom line is we need new management - if I’m wrong, please post

2 · Reply

kurtb1969 Jul. 3 at 4:43 PM

0 · Reply

kurtb1969 Jul. 3 at 4:35 PM

$MYO big baggies hates me because I believe exo skeletons are the future and I believe $MYO, $EKSO and $LFWD are the exo trifecta and are connected. No one wanted to buy $MYO 2 and a half years ago and because of tax loss selling was down to 50 cents. They ended up diluting existing shareholders by selling 20 million shares for 33 cents a share on 1/7-10/23. I was livid because I had 220k and was down $60K and if they waited 2 months they would have gotten a better price. This year so far myo is down 67 percent, ekso down 60 percent and lfwd down 60 percent. I believe they are connected and now they are at the bottom.

1 · Reply

Astondb9 Jul. 3 at 2:26 PM

$MYO rejected 5dma (2.15) again. Lower bb 1.89. Expense > Revenue = an issue. Pushing out breakeven cf time frame means erosion of cash-->requiring further dilution. That's what the mkt is sniffing out.

1 · Reply

NickMitchell Jul. 2 at 9:35 PM

$MYO i blame Obama

2 · Reply

Rroper Jul. 2 at 9:27 PM

$MYO Loaded a few more today. Slow and steady. Next year play. Paytience.

1 · Reply

alexpitti Jul. 2 at 9:06 PM

weak sector starting in early june especially $DCTH and $MYO

0 · Reply

kurtb1969 Jul. 2 at 6:39 PM

$MYO very excited unloaded all my shares over $5 and now I'm fully loaded again. I believe the bad 2nd is over the outlook should be good.Myo exceeds estimates every quarter and now I'm up to a lucky 66600 shares.

2 · Reply

Astondb9 Jul. 2 at 2:09 PM

$MYO another day, another 5dma rejection while lower daily bb dips lower and lower. Now at 1.96 🫣😬🤕🤮🥴🥺

0 · Reply

alexpitti Jul. 2 at 4:17 AM

$MYO is myomo really doing terrible or is Q2 one bad quarter? numbers don't lie

1 · Reply

alexpitti Jul. 2 at 4:14 AM

$MYO I actually do think the narrative among retail investors is important because this is a pretty tiny stock. and if that's the case, a lot of the negativity is rooted in anger more than actual math and facts. i don't think many actually watched the investor meeting nor have they done the math and completed a valuation model on 2028 numbers. sure anyone can argue that they want myomo to grow faster in the next few years. but that's simply and irrelevant point because the market isn't even pricing in them hitting the 2028 guidance in the first place. in fact, the market isn't pricing in any growth at all. that's why we have a below 2x sales multiple

1 · Reply

Big_Baggies Jul. 1 at 6:38 PM

$MYO 11 days in a row of lower highs? What a mess. Very much a turd.

2 · Reply

fitchbuck Jul. 1 at 4:47 PM

$MYO Everyone - take off your rose-colored-glasses-of-ownership for a second, put the hopium pipe down, and take a serious stab at answering these: When do believe the stock price sees $5 again? What do you put the % chance that this never gets to $5 again? (Hint: it's not 0.)

5 · Reply

Astondb9 Jul. 1 at 3:40 PM

$MYO 2.23 is the 5dma. Bounced off lower daily bb. Will it reject and head back to lower bb? Still believe weekly bb is the target 1.7

1 · Reply

Market Cap	73.04M
Revenue (ttm)	32.55M
Net Income (ttm)	-6.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.99%
Debt to Equity Ratio	0.00

Volume	403,500
Avg Vol	672,568
Day's Range	N/A - N/A
Shares Out	35.98M
Stochastic %K	3%
Beta	1.39
Analysts	Strong Sell
Price Target	$8.70